Prognostic efficacy and prognostic factors of TACE plus TKI with ICIs for the treatment of unresectable hepatocellular carcinoma: A retrospective study

Hepatocellular carcinoma (HCC) remains a global challenge due to its high morbidity and mortality rates as well as poor response to treatment. Local combined systemic therapy is widely used in the treatment of unresectable hepatocellular cancer (uHCC). This retrospective study was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ziqiang, Yang, Faji, Zhang, Ye, Wang, Jianlu, Ni, Qingqiang, Zhu, Huaqiang, Zhou, Xu, Gao, Hengjun, Lu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798199/
https://www.ncbi.nlm.nih.gov/pubmed/36591442
http://dx.doi.org/10.3389/fonc.2022.1029951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798199/
https://www.ncbi.nlm.nih.gov/pubmed/36591442
http://dx.doi.org/10.3389/fonc.2022.1029951

Ejemplares similares